Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G

The Journal of Clinical Investigation
E C LianL L Chiu

Abstract

Plasma from patients with thrombotic thrombocytopenic purpura (TTP) caused the aggregation of autologous and homologous platelets, and effect which was inhibited by normal plasma. IgG purified from seven normal adults at a concentration of 0.7 mg/ml completely inhibited the platelet aggregation induced by plasma obtained from two TTP patients with active disease. The inhibition of platelet aggregation by human adult IgG was concentration dependent, and the inhibitory activity of human IgG was neutralized by rabbit antihuman IgG. Fab fragments inhibited the TTP plasma-induced platelet aggregation as well as intact IgG, whereas Fc fragments had no effect. Platelet aggregation caused by ADP, collagen, epinephrine, or thrombin was not affected by purified human IgG. The prior incubation of IgG with TTP plasma caused a significantly greater reduction of platelet aggregation by TTP plasma than that of IgG and platelet suspension, suggesting that the IgG inhibits TTP plasma-induced platelet aggregation through direct interaction with platelet aggregating factor in TTP plasma. IgG obtained initially from five infants and young children under the age of 4 yr did not possess any inhibitory activity. When one of the children reached 3 yr ...Continue Reading

References

Jan 1, 1979·Journal of Immunological Methods·R C DuhamelE Meezan
Dec 22, 1977·The New England Journal of Medicine·R H Aster
Nov 1, 1978·Annals of Internal Medicine·J AnsellL Pechet
Oct 31, 1977·JAMA : the Journal of the American Medical Association·J Morrison, R McMillan
Jun 1, 1977·British Journal of Haematology·P N WalshJ G White
May 1, 1975·Scandinavian Journal of Haematology·N Berman, J Z Finklestein
May 5, 1973·British Medical Journal·R C BrownP J Toghill
Jun 24, 1983·Science·D N SlatkinH W Siegelman
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·N C SharmaR G Mason
Jan 1, 1980·Seminars in Thrombosis and Hemostasis·P B Neame
Jan 1, 1981·Seminars in Thrombosis and Hemostasis·J J Byrnes
Apr 22, 1962·Orvosi hetilap·P ORMOSI NYIRI

❮ Previous
Next ❯

Citations

Jan 1, 1990·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J M Bergstein
Nov 1, 1992·Annals of Hematology·A Cerveró MartiM Sanchez
Feb 5, 1998·British Journal of Haematology·P A ValantY S Ahn
Apr 11, 1985·The New England Journal of Medicine·R H Aster
Feb 6, 1986·The New England Journal of Medicine·P WongS Yoshida
May 1, 1992·Postgraduate Medical Journal·D CameronM Turner
Oct 1, 1985·The Journal of Clinical Investigation·F A Siddiqui, E C Lian
Aug 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D P RanieleC M Kjellstrand
Jan 1, 1988·Kidney International·M D WaltersT M Barratt
Jan 1, 1993·Nihon rinsho. Japanese journal of clinical medicine·T Koyama, E Kakishita
Mar 31, 1999·Baillière's Clinical Haematology·A Eldor
Jan 24, 2006·Blood Reviews·R J A Murrin, J A Murray
Jul 27, 2001·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·U E Nydegger, T Sturzenegger
Jan 1, 1987·Annals of the New York Academy of Sciences·J G Kelton, W G Murphy
May 1, 1992·Postgraduate Medical Journal·J TattersallK Farrington
Jan 1, 1986·Critical Reviews in Clinical Laboratory Sciences·E Patten
Aug 1, 1996·American Journal of Hematology·R LiangI K Cheng
Jan 1, 1994·American Journal of Hematology·C Porta, E Bobbio-Pallavicini
Jul 1, 1988·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·C LoiratJ Fermanian
Mar 1, 1988·American Journal of Hematology·B R MeisenbergM P Kosty
Aug 1, 1987·American Journal of Hematology·H H SalemB G Firkin
Jun 30, 1990·Lancet·H J LenzH D Waller
Sep 1, 1994·Baillière's Clinical Haematology·S D Wright, E G Tuddenham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.